ENVB

Enveric Biosciences, Inc.

Nasdaq · Pharmaceutical Preparations · EDGAR filings (CIK 890821) · 4 signals · 1 setups · updated Aug 16, 2026

What the filings say Pressure ▼

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.

Radar 67 (elevated attention) · dilution pressure elevated · listing risk low · governance risk low · runway n/a · strongest signal: ATM program (Aug 14, 2026)

What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

67Radar · attention score (0–100)

61Dilution pressure · financing + balance sheet

28Listing risk · exchange standards

29Governance risk · reporting, auditor, going concern

Setups

Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.

Forced-raise setup Pressure ▼ strength 0.70

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (going-concern language) coexists with live selling machinery (atm program). Base case is a discounted raise; the question is when, not if.

Would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
Would invalidate: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).

ATM programGoing-concern language

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on ENVB

Alerts

One email the morning ENVB files anything that matches your rules (types, minimum score, setups).

12-month history

Every signal and setup for ENVB back a year, not just 30 days — see how the current setup built.

Full analyst notes

What we noticed, evidence with links, what could prove us wrong, red-team caveats.

Full screener + CSV

All 985 flagged companies, same-day, sortable and exportable.

Get Pro · $18.85/mo founding rate See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

n/acash + short-term investments

n/aestimated runway (4x latest quarterly operating cash burn)

$8.1Mstockholders' equity as of Jun 30, 2026

$3.6Mpublic float (10-K cover)

4.5Mshares outstanding as of Aug 12, 2026 · was 1.9M Mar 24, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

Date	Signal	Evidence	Score
Aug 16, 2026	▼ Share count +25%	Shares outstanding 1,887,535 (2026-03-24) -> 4,475,884 (2026-08-12), +137% filing	41
Aug 16, 2026	▼ Near $5M MVLS floor	Public float $3,600,000 (as of 2025-06-30) vs $5M Nasdaq MVLS floor; needs price x shares confirmation filing	28
Aug 14, 2026	▼ ATM program	“atm” language in 8-K (EX-99.1) filed 2026-08-14 filing	41
Aug 14, 2026	▼ Going-concern language	“going concern periodic” language in 10-Q (10-Q) filed 2026-08-14 filing	29

Other forced raise setups

VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans